Trial Profile
A Multicentre, Randomised, Active Comparator, Parallel Group Study To Compare The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2019
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary) ; Zonisamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms COGZ
- Sponsors Eisai Co Ltd
- 12 Apr 2019 According to Eudra record the trial has been discontinued in spain.
- 31 Oct 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 28 Apr 2012 Additional trial locations identified as reported by EudraCT.